A special White House email was created for "‘concierge service’ on these offers and requests," according to email sent by former deputy @WHNSC director Matthew Pottinger in March. /2
In March WH meeting, @ScottGottliebMD and Dr. Fauci fought to preserve @US_FDA authority on #hydroxychloroquine, after @SecAzar dangled stroke-of-pen authorization. Trump silenced Azar mob-style, w/ finger to lips. /4
As COVID spread, @US_FDA got early admonition from @HHSGOV to slow down early outreach to diagnostic test makers, and be "reactive," not "proactive," according to an internal email. /5
Career FDA officials besieged by Oleandrin pitches, backed by @MyPillowUSA CEO Mike Lindell. @US_FDA investigator uncovers: extract given to workers at TX meat-packing plant, nursing home, possible human subject violations. /6
Rookie commissioner @SteveFDA tells colleagues @HHSGov is "evil." Says to @VanityFair he found DC's political lies unnerving: "It is very unusual in hospital medicine that someone lies, because people die.” /END
• • •
Missing some Tweet in this thread? You can try to
force a refresh
BREAKING: My latest @VanityFair story, a detailed investigation into how the White House secretly drafted, then abandoned, a plan to nationalize America's broken #COVID19 diagnostic testing system. vanityfair.com/news/2020/07/h… /1
The plan, reported for 1st time here, was killed amid shifting WH logic: “political folks believed that because [virus] was going to be relegated to Democratic states, that they could blame those governors, and that would be an effective political strategy....” @ProjectLincoln/2
WH secretly procured 3.5 million Chinese-made diagnostic tests from UAE company. Tests, delivered to @UAEEmbassyUS, didn't work. The invoice simply lists client name as "WH". Without a legit gov't contract, invoice cannot be paid. @COVIDOversight@weareoversight /3
1) With #BottleofLies just out in paperback, I wanted to revisit its key disclosures, the book's impact and explore: has our fraud-fueled drug-quality crisis changed for better or worse? @eccobooks@AltFda Thread 👇
2) #BottleofLies recounts wild fraud at India's largest Rx co. Ranbaxy, maker of low-cost meds 4 US patients including 1st version of generic Lipitor (which contained glass particles/pic below). Ranbaxy would be operating today had @D_S_Thakur not risked his life to expose truth.
3) Ranbaxy's fraud was encapsulated in a smoking-gun internal PPT shown to company directors: the company had registered over 200 products in more than 40 countries using fake data. For 1st time, I am making the full doc available here: katherineeban.com/new-page@PeterAttiaMD
1/With today's @US_FDA decision to end emergency authorization for #hydroxychloroquine to treat #COVID19, let's revisit the clues that this miracle cure, touted by @POTUS, was politics, not science, from the start politi.co/2YGa59C (thread)
2/Right away, the FDA's emergency use authorization (EUA) allowed for plummeting quality standards. Stockpile chloroquine phosphate from uninspected Rx plants in Pakistan + India? Why not? reut.rs/2UOo5x7
3/The compromise was worth it, supposedly, because the drug was a #gamechanger, as @POTUS proclaimed. As the Trump administration secretly planned to flood NY + NJ w/ millions of doses, gov't scientists rightly resisted: vanityfair.com/news/2020/04/i…
With the news from India that former Ranbaxy CEO Malvinder Singh and his brother Shivinder have been arrested for alleged fraud, I want to offer a few thoughts from my decade of reporting #BottleofLies. (1)
Malvinder Singh was complicit in Ranbaxy's ongoing fraud. He was at the Oct. 14, 2004 boardroom meeting when @D_S_Thakur's explosive PPT (1 page below) alleging global data falsification, was shown to board members. (2)
Ranbaxy's top officials embarked on a cover-up, ordering destruction of PPT + laptop. Company secretary was sent from room and meeting minutes were later forged. The buried PPT (known as Self Assessment Report or SAR) became Ranbaxy's Kryptonite. (3)
No easy way to answer that question. But…I’ve put together a short guide for the worried + curious: How to Investigate Your Own Drugs. @alt_fda@d_s_thakur@blakeleymusic Below info will be up on my website katherineeban.com soon [2]
Step 1: Find Out Who Manufactures Your Drug. That info is usually on the dispensing label. You can call the pharmacist to ask; that way, you can request a manufacturer change in advance, if need be. (More on that in a min.) @NCLEXprof@PlumHealthDPC [3]
Friends, my book Bottle of Lies: The Inside Story of the Generic Drug Boom comes out today. When this journey began 10 yrs ago, I never thought it would lead me to expose egregious fraud in overseas generic drug plants we rely on. Looking back, here are a few key moments (thread)
2) My journey began in 2008 w/ a phone call from @JoeGraedon, co-host of @NPR’s @PeoplesPharmacy. His inbox was flooded w/ patients getting sick after being switched from brand-name to generic Rx. My scribbled notes held a question: what is wrong w/ the drugs?
3) My first story in @SELFmagazine described patient/MD struggles w/ generic Rx. Then-prez of @APAPsychiatric told me: “The FDA is satisfied that generics are ok. My question is, `Are we satisfied?’”